ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin
Enforcement Report - Week of December 6, 2023
Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drug
Zydus Lifesciences' Generic Indomethacin Receives Approval in US
Indomethacin is shown to be highly efficient in treating the Covid infection as per a study conducted by Dr Rajan Ravichandran, director nephrology, MIOT Hospitals and Prof R Krishna Kumar, Institute Professor, IIT Madras in India.
In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1, the price of that same box was 52 times higher, totaling $10,350.
Enforcement Report - Week of August 8, 2018
Zydus Pharm’s Generic Indomethacin Receives Approval In US
Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market indomethacin extended release capsules used in treating painful and inflammatory conditions such as arthritis.
Jubilant's Generic Indomethacin Receives Approval In US